Histocell Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Histocell General Information

Description

Developer of regenerative medicine biopharmaceutical products designed to improve people's quality of life. The company offers cell therapy, biological medicinal products, innovative medical devices and dermo-cosmetic products, enabling healthcare providers and patients to access advances in regenerative medicine for therapeutic and cosmetic purposes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parque Tecnológico 801 A, 2
  • 48160 Derio
  • Spain
+34 946
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Therapeutic Devices
Personal Products
Parent Company
Vertical(s)
Corporate Office
  • Parque Tecnológico 801 A, 2
  • 48160 Derio
  • Spain
+34 946

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Histocell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 12-Dec-2022 Completed Profitable
8. Later Stage VC 17-Sep-2018 Completed Profitable
7. Grant 12-Dec-2016 Completed Profitable
6. Later Stage VC 30-Sep-2016 Completed Profitable
5. Later Stage VC 01-Jan-2012 Completed Profitable
4. Debt - General 01-Dec-2011 Completed Generating Revenue
3. Later Stage VC 15-Dec-2009 Completed Generating Revenue
2. Merger/Acquisition 01-Jan-2006 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Histocell’s complete valuation and funding history, request access »

Histocell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 9,574 $11.611857 $576.75 $576.75 1x $576.75 11.11%
To view Histocell’s complete cap table history, request access »

Histocell Patents

Histocell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3143472-A1 Antioxidant composition for wound healing Active 24-Jul-2019
EP-4005608-A1 New antioxidant composition for wound healing Active 24-Jul-2019
EP-4005608-B1 New antioxidant composition for wound healing Active 24-Jul-2019
EP-4005608-C0 New antioxidant composition for wound healing Active 24-Jul-2019
ES-2978950-T3 New antioxidant composition for wound healing Active 24-Jul-2019 A61K36/9066
To view Histocell’s complete patent history, request access »

Histocell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Histocell Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cell Innovation Partners Venture Capital Minority
Elkarkidetza Corporation Minority
Gestión de Capital Riesgo del País Vasco Venture Capital Minority
Grupo IMQ Corporation Minority
Horizon 2020 Government
You’re viewing 5 of 9 investors. Get the full list »

Histocell Investments (1)

Histocell’s most recent deal was a Joint Venture with Histokine. The deal was made on 06-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Histokine 06-Aug-2024 Joint Venture Other Pharmaceuticals and Biotechnology
To view Histocell’s complete investments history, request access »

Histocell FAQs

  • When was Histocell founded?

    Histocell was founded in 2004.

  • Where is Histocell headquartered?

    Histocell is headquartered in Derio, Spain.

  • What is the size of Histocell?

    Histocell has 42 total employees.

  • What industry is Histocell in?

    Histocell’s primary industry is Biotechnology.

  • Is Histocell a private or public company?

    Histocell is a Private company.

  • What is Histocell’s current revenue?

    The current revenue for Histocell is .

  • How much funding has Histocell raised over time?

    Histocell has raised $17M.

  • Who are Histocell’s investors?

    Cell Innovation Partners, Elkarkidetza, Gestión de Capital Riesgo del País Vasco, Grupo IMQ, and Horizon 2020 are 5 of 9 investors who have invested in Histocell.

  • When was Histocell acquired?

    Histocell was acquired on 12-Dec-2022.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process